|
Volumn 34, Issue 2, 2002, Pages 722-
|
Prostate cancer in renal transplant recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
ADULT;
AGED;
ANTIGEN DETECTION;
ARTICLE;
CANCER DIAGNOSIS;
CANCER HORMONE THERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER SCREENING;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL EXAMINATION;
CONTROLLED STUDY;
FOLLOW UP;
FRANCE;
HEALTH SURVEY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
MEDICAL SOCIETY;
MULTIMODALITY CANCER THERAPY;
PATIENT CARE;
POPULATION RESEARCH;
PREVALENCE;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CARCINOMA;
PROSTATECTOMY;
QUESTIONNAIRE;
RECIPIENT;
RECTUM;
SCORING SYSTEM;
TREATMENT OUTCOME;
FRANCE;
HUMANS;
IMMUNOSUPPRESSION;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LYMPH NODE EXCISION;
MALE;
NEOPLASM STAGING;
PREVALENCE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
QUESTIONNAIRES;
SURVIVAL RATE;
|
EID: 0036257691
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02624-6 Document Type: Article |
Times cited : (13)
|
References (4)
|